Medication Abortion Resources
Announcing the Pharmacists CARE Initiative to Increase Access to Reproductive Health Services in California
$2 Million Contract Awarded to the Pharmacists CARE Initiative to Expand Medication Abortion Services in California Birth Control Pharmacist, in partnership with the California Pharmacists Association (CPhA) and the CPhA Foundation, is proud to announce the receipt of a transformative $2 million grant from the California Department of Health Care Access and Information. Over the…
Misoprostol-Only Medication Abortion Regimen
Political Climate After the U.S. Supreme Court’s decision to eliminate the constitutional protections for abortion in Dobbs v. Jackson Women’s Health Organization in June 2022, access to mifepristone and abortion services in general are being threatened across the country. An ongoing anti-abortion lawsuit in Texas seeks to reverse mifepristone’s FDA approval and remove it from…
Pharmacists Can Now Dispense Mifepristone Under Updated REMS Program
What Does the January 2023 Update Mean for Mifepristone Dispensing? Mifepristone is a medication that is used to end an early pregnancy. It has been available in the United States since 2000 and is widely used as a safe and effective option for ending a pregnancy during the first 10 weeks. As of January 2023,…
Upcoming Changes to the Mifepristone REMS Program: Implications for Pharmacy Practice
Pharmacists in the community setting may soon have the opportunity to ease access to medication abortion in the United States. In the coming months, mifepristone (Mifeprex) is anticipated to have an updated Risk Evaluation and Mitigation Strategy (REMS) Program that allows dispensing through local brick-and-mortar and mail-order pharmacies. This change will integrate pharmacists into abortion…
Present and Future Pharmacist Roles in Medication Abortion Care
Although there are currently restrictions on the ways that patients can obtain a medication abortion, this many soon change and pharmacists will be an important part of access.
Medication Abortion Curriculum: A Pharmacy Student Perspective
New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.
Reproductive Health During COVID: Eliminating FDA’s Burdensome Barriers to Mifepristone
What is Mifepristone? Mifepristone is the primary component in the FDA-approved regimen taken to terminate pregnancies through 10 weeks gestation and is seen as an alternative to a surgical procedure.1 Many patients view this as less invasive, allowing for more privacy and control over a personal situation. The standard oral regimen includes mifepristone 200mg followed…